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At the recent BASHH Annual Conference,
there were numerous presentations refer-
ring to home-sampling or testing, often-
times interchangeably and inconsistently,
despite these being distinct methodolo-
gies. Furthermore, by specifying ‘home’ as
opposed to ‘self ’, the sampling or testing
is constrained to the home environment.
With diagnostic advances enabling modi-
ﬁed care pathways, we urge that these
terms be used consistently.
The WHO deﬁnes HIV self-testing as ‘a
process whereby a person who wants to
know his or her HIV status collects a spe-
cimen, performs a test and interprets the
test result in private’.1 In contrast, self-
sampling requires individuals to send their
specimens to a laboratory where they are
tested, and the laboratory returns the test
result to the individual.
Self-sampling for HIV and STIs is cur-
rently available in the UK from a number of
public and private providers. Self-testing is
a nascent ﬁeld, with only one HIV self-test
currently licensed in the UK and validated
self-tests for STIs still in development
(http://www.esti2.org.uk).
Consistent terminology is crucial given
the implications for research, policies, regu-
lations, intervention development, pro-
gramme delivery and care pathway provision
(including result conﬁrmation, treatment
and partner notiﬁcation). For surveillance,
Public Health England’s genitourinary medi-
cine clinic activity dataset (GUMCADv2)
surveillance system introduced the REF3 sur-
veillance code in 2015 to identify individuals
referred from self-testing and sampling ser-
vices. While enabling an assessment of react-
ive test results from self-collected specimens,
this code does not differentiate between self-
sampling and self-testing, and will therefore
need modiﬁcation as self-testing expands to
ensure the collection of robust surveillance
data.2
As options for STI and HIV self-
sampling and self-testing continue to
expand, we urge colleagues to be consist-
ent and to deﬁne the terminology used in
order to limit confusion for both profes-
sionals and patients.
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